Vivani Medical, Inc.

NASDAQ:VANI

Medical - Devices

Healthcare
$1.05 +1.30%

+$0.02 today

Market cap
$94.71M
Beta
3.29
P/E (TTM)
-3.5
EPS (TTM)
-$0.33
52W Low $0.92High $1.92

Volume 0.18M

Average 0.24M

VANI Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Vivani Medical, Inc.NASDAQ: VANI

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 81.27M shares rose 37.2% year over year, ahead of the +15.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 30.3% from the prior quarter. Over 3 fiscal years it compounded at +17.7% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +37.2% holds above the trailing-twelve-month pace of +15.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
81.27M+30.3% QoQ
Last fiscal yearDec 2025
62.39M+13.5% YoY
LTMMar 2026
65.65M+15.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+37.2%——
1 year+13.5%——
3-year CAGR+17.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
62.39M USD
Year-over-year change
+13.5%
4-year CAGR
+14.5%

Weighted Avg Shares (Diluted) vs competitors

How VANI compares with its peers on the latest reported figures

  • VANI's LTM Mar 2026 weighted avg shares (diluted) of 65.65M shares is the 3rd highest of the 8 companies compared; the peer median is 42.44M shares.
  • Its year-over-year change of +15.7% is the 4th highest of 8, against a peer median of +3.8%.
  • Over three fiscal years its annual growth of +17.7% compares with a peer median of +3.7%.
VANI Competitors Peer median
Weighted Avg Shares (Diluted) for VANI and competitors
Company Period LTM YoY 3-year CAGR
CRDLCardiol Therapeutics Inc.LTM Mar 202694.16M +29.4%+11.6%
HYPRHyperfine, Inc.LTM Mar 202687.25M +18.9%+10.2%
VANIVivani Medical, Inc.LTM Mar 202665.65M +15.7%+17.7%
MBOTMicrobot Medical Inc.LTM Mar 202654.72M +234.9%+84.8%
ORMPOramed Pharmaceuticals Inc.LTM Mar 202642.44M +3.8%+2.8%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
IMAImageneBio IncLTM Mar 202619.79M -59.0%-48.8%
FONRFONAR CorporationLTM Mar 20266.39M -4.2%-0.7%
Peer median (excluding VANI) 42.44M+3.8%+3.7%

Competitors are the stored peer set for VANI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00357K0424K
Gross Profit00(357K)0(424K)
Gross Margin—————
Research & Development11M14.17M16.97M15.75M18.13M
Selling, General & Admin2.32M5.37M10M8.93M9.43M
Operating Expenses13.32M21.24M26.61M24.68M27.13M
Depreciation & Amortization345K381K357K400K424K
EBITDA(12.43M)(19.16M)(25.3M)(23.09M)(26.19M)
EBITDA Margin—————
Operating Income(13.32M)(21.24M)(26.97M)(24.68M)(27.56M)
Operating Margin—————
Interest Income00000
Interest Expense00000
Other Income / Expenses550K7.35M1.31M1.19M947K
Income Before Tax(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(12.77M)(13.89M)(25.65M)(23.49M)(26.61M)
Net Margin—————
EPS (Basic)(0.33)(0.17)(0.50)(0.43)(0.43)
EPS (Diluted)(0.33)(0.17)(0.50)(0.43)(0.43)
Weighted Avg Shares36.25M38.24M50.85M54.98M62.39M
Weighted Avg Shares (Diluted)36.25M38.24M50.85M54.98M62.39M

Vivani Medical, Inc.

NASDAQ:VANI

Intrinsic Alpha fair value

Locked

Current Price

$1.05

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.